Paul E Di Corleto Net Worth

The estimated Net Worth of Paul E Di Corleto is at least $101 mil dollars as of 21 May 2013. Paul Corleto owns over 6,210 units of Cytocom Inc stock worth over $101,015 and over the last 17 years Paul sold CBLI stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Paul Corleto CBLI stock SEC Form 4 insiders trading

Paul has made over 2 trades of the Cytocom Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently Paul bought 6,210 units of CBLI stock worth $9,998 on 21 May 2013.

The largest trade Paul's ever made was buying 10,000 units of Cytocom Inc stock on 15 August 2011 worth over $26,000. On average, Paul trades about 1,474 units every 59 days since 2007. As of 21 May 2013 Paul still owns at least 31,866 units of Cytocom Inc stock.

You can see the complete history of Paul Corleto stock trades at the bottom of the page.

What's Paul Corleto's mailing address?

Paul's mailing address filed with the SEC is 11000 CEDAR AVE., SUITE 280, CLEVELAND, OH, 44106.

Insiders trading at Cytocom Inc

Over the last 17 years, insiders at Cytocom Inc have traded over $1,157,190 worth of Cytocom Inc stock and bought 66,403 units worth $199,902 . The most active insiders traders include James Antal, Michael Fonstein, eBernard L Kasten. On average, Cytocom Inc executives and independent directors trade stock every 101 days with the average trade being worth of $21,921. The most recent stock trade was executed by Langdon L Miller on 22 July 2021, trading 10,000 units of CBLI stock currently worth $30,000.

What does Cytocom Inc do?

Complete history of Paul Corleto stock trades at Cytocom Inc

Cytocom Inc executives and stock owners

Cytocom Inc executives and other stock owners filed with the SEC include:

• Christopher Zosh,
  Interim Principal Executive Officer and Principal Financial Officer, Vice President of Finance
• Langdon Miller,
  President, Chief Medical Officer
• Andrei Gudkov,
  Chief Scientific Officer
• Lea Verny,
  Independent Chairman of the Board
• Daniil Talyanskiy,
  Independent Director
• Randy Saluck,
  Independent Director
• Anna Evdokimova,
  Independent Director
• Alexander Andryushechkin,
  Independent Director
• Ivan Fedyunin,
  Independent Director
• Anthony Principi,
  Director
• C Neil Lyons,
  Chief Financial Officer
• Elena Kasimova,
  Director
• Yakov Kogan,
  EVP of Bus. Development, Sec.
• Richard Mc Gowan,
  Director
• James Antal,
  Director
• Daniel Floyd Jr Hoth,
  Director
• Julia R Brown,
  Director
• Alexander Polinsky,
  Director
• David C Hohn,
  Director
• Bernard L Kasten,
  Director
• Jean Viallet,
  Chief Development Officer
• Paul E Di Corleto,
  Director
• Michael Fonstein,
  CEO & President
• Hector Daniel Perez,
  Director
• John A Jr Marhofer,
  Chief Financial Officer
• Securities Corp Sunrise,
  10% owner
• Michael K Handley,
  President and CEO
• Robert Buckheit,
  Chief Technology Officer
• Cozette M. Mc Avoy,
  Chief Legal Officer
• Clifford Selsky,
  Chief Medical Officer
• Peter Aronstam,
  Chief Financial Officer